Probiotic for inhibiting clostridium perfringens, and screening method and application thereof
A Clostridium perfringens and screening method technology, applied in the biological field, can solve problems affecting growth and development, shock and even death, and achieve the effect of improving weight loss, improving the structure of intestinal flora, and reducing the diarrhea rate of mice
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] Example 1 strain screening:
[0030] (1) Preliminary screening of Bacillus with antibacterial ability from pig-derived intestinal contents and feces
[0031] Take 1g of jejunum, ileum intestinal content and feces samples from 180-day-old Jinhua pigs, dilute them with sterilized normal saline at a ratio of 1:10, bathe in 75°C water for 15 minutes, and then dilute them in a 10-fold gradient with sterile water. -3 、10 -4 、10 -5 、10 -6 For four dilution gradients, draw 100 μL of the bacterial suspension and spread it on the LB plate, at least 3 plates for each dilution gradient, cool the upper layer of the LB semi-solid medium to about 50°C, add 5% of the activated product Clostridium perfringens (ATCC 13124), after mixing, pour it into the upper plate immediately and spread it, place it in a constant temperature incubator at 37°C for 12 hours, make at least 3 plates for each dilution gradient and each pathogenic bacteria, and screen Bacillus having the ability to inhib...
Embodiment 2
[0055] Example 2: Identification of strain BA40
[0056] The 16S 16S rDNA of the strain BA40 of the present invention was sequenced, and compared with the NCBI database by Blast, it was shown that the homology between BA40 and the type strain Bacillus amyloliquefaciens AB301002.1 was 99.72%, and the homology with the type strain Bacillus amyloliquefaciens KX137853.1 was 99.38% %, so it was determined to be Bacillus amyloliquefaciens. Strain BA40 was deposited in China Center for Type Culture Collection, No. 299 Bayi Road, Wuchang District, Wuhan City, Hubei Province on May 17, 2021, and the preservation number is CCTCC NO: M2021535.
Embodiment 3
[0057] Example 3 Application of Bacillus amyloliquefaciens BA40 to prevent Clostridium perfringens infection
[0058] 1) Preparation of probiotic bacteria liquid
[0059] Inoculate the Bacillus amyloliquefaciens BA40 described in claim 6 in the LB liquid medium, and culture it on a shaking table at 37° C. for 12 hours, so that the concentration of the bacterial solution reaches 1.0×10 8 ~1.0×10 9 CFU / mL, prepare Bacillus amyloliquefaciens BA40 bacterial liquid; follow the same method, prepare bacterial liquid for commercially available Bacillus subtilis PB6.
[0060] 2) Application of probiotic liquid
[0061] 24 6-week-old C57B / L mice were selected and randomly divided into four groups, namely control group, Clostridium perfringens infection group, BA40+Clostridium perfringens infection group, PB6+Clostridium perfringens infection group, and PB6+Clostridium perfringens infection group. infection group. The BA40+Clostridium perfringens infection group was orally administe...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com